Shell plc (LON:SHEL – Get Free Report) has been given a consensus rating of “Buy” by the six ratings firms that are presently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock in the last year is GBX 3,169.71 ($40.09).
A number of equities research analysts have recently weighed in on SHEL shares. Bank of America restated a “buy” rating and set a GBX 3,300 ($41.74) target price on shares of Shell in a research report on Monday, April 22nd. Royal Bank of Canada reissued an “outperform” rating and set a GBX 3,000 ($37.95) price objective on shares of Shell in a report on Friday, May 3rd. Finally, Barclays reaffirmed an “overweight” rating and issued a GBX 3,800 ($48.06) target price on shares of Shell in a research note on Friday, May 3rd.
Check Out Our Latest Stock Analysis on Shell
Shell Stock Performance
Shell Announces Dividend
The business also recently announced a dividend, which was paid on Monday, June 24th. Stockholders of record on Thursday, May 16th were given a dividend of $0.34 per share. The ex-dividend date was Thursday, May 16th. This represents a dividend yield of 0.98%. Shell’s payout ratio is currently 5,069.77%.
About Shell
Shell plc operates as an energy and petrochemical company Europe, Asia, Oceania, Africa, the United States, and Rest of the Americas. The company operates through Integrated Gas, Upstream, Marketing, Chemicals and Products, and Renewables and Energy Solutions segments. It explores for and extracts crude oil, natural gas, and natural gas liquids; markets and transports oil and gas; produces gas-to-liquids fuels and other products; and operates upstream and midstream infrastructure to deliver gas to market.
Featured Stories
- Five stocks we like better than Shell
- What is a Death Cross in Stocks?
- RXO Shares Surge Following New Acquisition Deal
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Following Congress Stock Trades
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Shell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shell and related companies with MarketBeat.com's FREE daily email newsletter.